Olmin Trio Tablet
By Olmin Trio
15 Tablet in a Strip

Composition
Olmesartan Medoxomil(20mg) + Cilnidipine(10mg) + Chlorthalidone(12.5mg)

Manufacturer - Eris Lifesciences Ltd
8th Floor, Commerce House IV, Prahladnagar, Ahmedabad – 380015 Gujarat, India

Expires on or after
April, 2026

liver
Olmin Trio Tablet should be used with caution if you have liver disease. It may be necessary to adjust the dosage of the tablet in such cases, so remember to seek guidance from your doctor before using it. It is important to note that Olmin Trio Tablet is not recommended for individuals with severe liver disease.

kidney
Caution should be taken when using Olmin Trio Tablet in patients with severe kidney disease. Dose adjustment may be required, and it is advised to consult a doctor. Avoid using this tablet in patients with severe kidney issues.

alcohol
Olmin Trio Tablet can make you very drowsy when taken with alcohol.

driving
When taking Olmin Trio Tablet, be cautious while driving as it may reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if experiencing these effects.

pregnancy
Olmin Trio Tablet is not safe to use during pregnancy due to the risk to the developing baby. However, in life-threatening situations, a doctor may prescribe it if the benefits outweigh the risks. It is important to seek medical advice.

breastfeeding
It is better to consult your doctor before using Olmin Trio Tablet.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹319.18
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024